TABLE 5.
Estimated number of cancer death cases by age in Afghanistan male population, 2020.
| Cancer | Total | 0–14 | 15–39 | 40–44 | 45–49 | 50–54 | 55–59 | 60–64 | 65–69 | 70+ | Crude Rate | ASR (World) | Cum. risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach | 1228 (15.56%) | 2 | 66 | 25 | 68 | 129 | 189 | 216 | 206 | 327 | 6.1 | 14.9 | 3.85 |
| Lung | 993 (12.58%) | 4 | 40 | 48 | 90 | 130 | 165 | 170 | 147 | 199 | 5.0 | 11.5 | 2.52 |
| Esophagus | 547 (6.93%) | 20 | 16 | 35 | 55 | 75 | 85 | 84 | 177 | 2.7 | 6.9 | 2.24 | |
| Liver | 543 (6.88%) | 10 | 61 | 26 | 42 | 58 | 74 | 82 | 78 | 112 | 2.7 | 6 | 1.36 |
| Brain, central nervous system | 511 (6.48%) | 59 | 162 | 49 | 51 | 50 | 46 | 37 | 27 | 30 | 2.6 | 4 | 0.56 |
| Lip, oral cavity | 433 (5.49%) | 3 | 68 | 34 | 42 | 51 | 59 | 58 | 48 | 70 | 2.2 | 4.5 | 0.97 |
| Leukemia | 434 (5.50%) | 136 | 162 | 24 | 22 | 20 | 19 | 15 | 13 | 23 | 2.2 | 2.7 | 0.42 |
| Colorectum | 382 (4.84%) | 58 | 23 | 25 | 38 | 50 | 53 | 51 | 84 | 1.9 | 4.2 | ‐ | |
| Prostate | 272 (3.45%) | 6 | 3 | 2 | 5 | 24 | 48 | 63 | 121 | 1.4 | 3.7 | 1.26 | |
| Non‐Hodgkin lymphoma | 259 (3.28%) | 27 | 81 | 19 | 21 | 23 | 23 | 21 | 18 | 26 | 1.3 | 2.1 | 0.37 |
| Kidney | 268 (3.40%) | 22 | 21 | 15 | 23 | 32 | 39 | 38 | 32 | 46 | 1.3 | 2.8 | 0.6 |
| Bladder | 234 (2.97%) | 10 | 6 | 10 | 20 | 31 | 40 | 41 | 76 | 1.2 | 2.9 | 0.8 | |
| Pancreas | 215 (2.72%) | 1 | 20 | 9 | 15 | 22 | 30 | 35 | 34 | 49 | 1.1 | 2.5 | 0.58 |
| Larynx | 155 (1.96%) | 8 | 4 | 9 | 17 | 25 | 31 | 28 | 33 | 0.78 | 1.8 | 0.4 | |
| Oropharynx | 68 (0.86%) | 1 | 4 | 2 | 6 | 7 | 10 | 12 | 10 | 16 | 0.34 | 0.77 | 0.16 |
| Nasopharynx | 63 (0.80%) | 5 | 22 | 7 | 6 | 4 | 5 | 6 | 4 | 4 | 0.32 | 0.5 | 0.07 |
| Hodgkin lymphoma | 63 (0.80%) | 20 | 20 | 3 | 3 | 4 | 4 | 3 | 2 | 4 | 0.32 | 0.41 | 0.05 |
| Testis | 59 (0.75%) | 14 | 28 | 4 | 3 | 3 | 3 | 2 | 1 | 1 | 0.3 | 0.35 | 0.03 |
| Multiple myeloma | 58 (0.74%) | 23 | 4 | 2 | 4 | 4 | 6 | 7 | 8 | 0.29 | 0.55 | 0.13 | |
| Hypopharynx | 44 (0.56%) | 4 | 2 | 1 | 3 | 5 | 8 | 9 | 12 | 0.22 | 0.52 | 0.12 | |
| Melanoma of skin | 37 (0.47%) | 1 | 8 | 4 | 1 | 2 | 3 | 5 | 5 | 8 | 0.19 | 0.38 | 0.09 |
| Gallbladder | 38 (0.48%) | 4 | 1 | 3 | 4 | 5 | 6 | 5 | 10 | 0.19 | 0.45 | 0.14 | |
| Thyroid | 28 (0.35%) | 1 | 4 | 1 | 3 | 4 | 5 | 5 | 3 | 2 | 0.14 | 0.28 | 0.04 |
| Salivary glands | 22 (0.28%) | 4 | 1 | 1 | 2 | 3 | 3 | 3 | 5 | 0.11 | 0.23 | 0.04 | |
| Kaposi sarcoma | 13 (0.16%) | 2 | 3 | 1 | 2 | 3 | 2 | 0.07 | 0.13 | 0.02 | |||
| Mesothelioma | 10 (0.13%) | 3 | 1 | 2 | 2 | 1 | 1 | 0.05 | 0.08 | 0.01 | |||
| Penis | 5 (0.06%) | 1 | 1 | 1 | 2 | 0.03 | 0.06 | 0.01 | |||||
| All cancers excluding non‐melanoma skin cancer | 7891 (100.00%) | 409 (3.99%) | 1018 (9.94%) | 394 (3.85%) | 569 (5.55%) | 789 (7.70%) | 1014 (9.90%) | 1098 (10.72%) | 1015 (9.91%) | 1585 (15.47%) | 39.5 | 84.3 | 18.06 |
Note: The incidence, prevalence proportions (prop.), crude rates, and ASR were reported per 100 000 people.